ReviewTherapeutic advances in neurological disorders2017

Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management.

Stefan Bittner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.